Pfizer, BioNTech Covid Vaccine Wins European Backing

Pfizer and BioNTech SE's Covid-19 vaccine won the backing of a key European review panel, clearing the way for inoculations to start before the end of the year as the continent struggles with rising death rates and tighter lockdowns. From a report: The endorsement was announced in a news briefing by the European Medicines Agency on Monday. The final step in approval is a sign-off from the European Commission. European Union leaders pushed the regulator to speed up its review amid complaints that residents across the continent were still waiting to get a vaccine -- pioneered in Germany -- that is already being used in the U.K. and U.S. The goal is to start a European immunization campaign on Dec. 27, commission President Ursula von der Leyen said last week. Monday's recommendation puts the EU in position to meet that timeline. The commission last week signaled it would give the official go-ahead for distribution to start no later than two days after the agency's sign-off.

Read more of this story at Slashdot.